Last update 08 May 2025

SKL-15508

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [3]
Target
CHRNA7
Action
agonists
Mechanism
α7 receptor agonists(Neuronal acetylcholine receptor protein alpha-7 subunit agonists)
Therapeutic Areas
Other Diseases
Active Indication
Cognition Disorders
Inactive Indication
Behavioural disordersSchizophrenia
Originator Organization
SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
Active Organization
SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
Inactive Organization
SK Life Science, Inc.SK Life Science, Inc.
License Organization
IGNIS Therapeutics (Shanghai) Co., Ltd.IGNIS Therapeutics (Shanghai) Co., Ltd.SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SKL-15508
KCT0002938
/ RecruitingPhase 1
A Phase 1, Randomized, Double-Blinded, Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study to Evaluate the Safety and Tolerability of SKL20540 in Healthy Subjects
NCT02205099
/ CompletedPhase 1/2
A Single-center, Randomized, Double-blind, Flexible-dosage, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
100 Clinical Results associated with SKL-15508
Login to view more data
100 Translational Medicine associated with SKL-15508
Login to view more data
100 Patents (Medical) associated with SKL-15508
Login to view more data
100 Deals associated with SKL-15508
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Behavioural disordersPhase 2
South Korea
SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
28 Nov 2018
SchizophreniaPhase 2
United States
SK Life Science, Inc.SK Life Science, Inc.
01 Jul 2014
Cognition DisordersPhase 2-
SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
-
Cognition DisordersPhase 2
United States
SK Biopharmaceuticals Co., Ltd.SK Biopharmaceuticals Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free